As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
The Speciality Care Division of Hetero Healthcare focuses on providing specialized therapeutic solutions for complex and chronic health conditions that require focused clinical management and long-term care.
Its portfolio addresses key areas such as immunology, infectious diseases, and other speciality therapies, supporting healthcare professionals in managing patients with specific and evolving treatment requirements.
Backed by Hetero Healthcare’s commitment to quality, innovation, accessibility, and patient-centric care, the Speciality Care Division strives to provide dependable therapies that support effective clinical management and better patient outcomes.
View by-
